balance 4.25 % glucose 1.25 mmol/l calcium peritonealdialysvätska
fresenius medical care deutschland gmbh - glukosmonohydrat; kalciumkloriddihydrat; magnesiumkloridhexahydrat; natriumklorid; natriumlaktatlösning - peritonealdialysvätska - natriumlaktatlösning 15,7 mg aktiv substans; kalciumkloriddihydrat 0,368 mg aktiv substans; magnesiumkloridhexahydrat 0,203 mg aktiv substans; glukosmonohydrat 93,5 mg aktiv substans; natriumklorid 11,28 mg aktiv substans - hypertona lösningar
balance 2.3 % glucose 1.25 mmol/l calcium peritonealdialysvätska
fresenius medical care deutschland gmbh - glukosmonohydrat; kalciumkloriddihydrat; magnesiumkloridhexahydrat; natriumklorid; natriumlaktatlösning - peritonealdialysvätska - kalciumkloriddihydrat 0,367 mg aktiv substans; natriumklorid 11,28 mg aktiv substans; natriumlaktatlösning 15,7 mg aktiv substans; magnesiumkloridhexahydrat 0,203 mg aktiv substans; glukosmonohydrat 50 mg aktiv substans - hypertona lösningar
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
ciprofloxacin mds 250 mg filmdragerad tablett
medical drug supplies ltd - ciprofloxacinhydroklorid (monohydrat) - filmdragerad tablett - 250 mg - ciprofloxacinhydroklorid (monohydrat) 291,1 mg aktiv substans; laktosmonohydrat hjälpämne - ciprofloxacin
ciprofloxacin mds 500 mg filmdragerad tablett
medical drug supplies ltd - ciprofloxacinhydroklorid (monohydrat) - filmdragerad tablett - 500 mg - ciprofloxacinhydroklorid (monohydrat) 582,2 mg aktiv substans; laktosmonohydrat hjälpämne - ciprofloxacin
ciprofloxacin mds 750 mg filmdragerad tablett
medical drug supplies ltd - ciprofloxacinhydroklorid (monohydrat) - filmdragerad tablett - 750 mg - ciprofloxacinhydroklorid (monohydrat) 873,3 mg aktiv substans; laktosmonohydrat hjälpämne - ciprofloxacin
carposekkur 100 mg/25 mg/200 mg filmdragerad tablett
sigillata ltd - entakapon; karbidopa (monohydrat); levodopa - filmdragerad tablett - 100 mg/25 mg/200 mg - sojalecitin hjälpämne; entakapon 200 mg aktiv substans; karbidopa (monohydrat) 27 mg aktiv substans; levodopa 100 mg aktiv substans - dekarboxylashämmare och comt-hämmare
carposekkur 125 mg/31,25 mg/200 mg filmdragerad tablett
sigillata ltd - entakapon; karbidopa (monohydrat); levodopa - filmdragerad tablett - 125 mg/31,25 mg/200 mg - entakapon 200 mg aktiv substans; sojalecitin hjälpämne; karbidopa (monohydrat) 33,75 mg aktiv substans; levodopa 125 mg aktiv substans - dekarboxylashämmare och comt-hämmare
carposekkur 150 mg/37,5 mg/200 mg filmdragerad tablett
sigillata ltd - entakapon; karbidopa (monohydrat); levodopa - filmdragerad tablett - 150 mg/37,5 mg/200 mg - sojalecitin hjälpämne; entakapon 200 mg aktiv substans; levodopa 150 mg aktiv substans; karbidopa (monohydrat) 40,5 mg aktiv substans - dekarboxylashämmare och comt-hämmare